Cite
HARVARD Citation
Walker, A. et al. (2021). Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study. Experimental dermatology. 30 (11), pp. 1686-1692. [Online].